Loading…
Adaptive Biotechnologies Corporation is projected to rise to $18.81 by 2027, a +36% move from its current price of $13.84. ADPT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $13.45 | $13.85 | $14.26 | +0.04% |
| May 30 | $13.29 | $13.85 | $14.44 | +0.08% |
| May 31 | $13.17 | $13.86 | $14.58 | +0.12% |
| Jun 1 | $13.07 | $13.86 | $14.70 | +0.16% |
| Jun 2 | $12.99 | $13.87 | $14.81 | +0.20% |
| Jun 3 | $12.91 | $13.87 | $14.91 | +0.24% |
| Jun 4 | $12.84 | $13.88 | $15.00 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.84 | $13.88 | $15.00 | +0.29% |
| Week 2 | $12.47 | $13.92 | $15.53 | +0.57% |
| Week 3 | $12.21 | $13.96 | $15.96 | +0.86% |
| Week 4 | $11.99 | $14.00 | $16.35 | +1.15% |
| Week 5 | $11.81 | $14.04 | $16.69 | +1.44% |
| Week 6 | $11.65 | $14.08 | $17.02 | +1.73% |
| Week 7 | $11.50 | $14.12 | $17.33 | +2.02% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Adaptive Biotechnologies Corporation is a healthcare company at the commercial stage that develops an immune medicine platform for the diagnosis and treatment of various diseases.
The company offers an immunosequencing platform which combines proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system.
It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient’s body during and after treatment, known as Minimal Residual Disease (MRD).
Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Adaptive Biotechnologies Corporation (ADPT) is a healthcare stock currently priced at $13.88. It has a market cap of $2.22B and is ranked 1929.
The overall price outlook is positive, with a year-by-year forecast showing growth in average price from 2026 through 2050. The 2026 avg is $13.88; 2027 avg is $18.92; 2030 avg is $23.19; 2040 avg is $59.42; and 2050 avg is $100.00.
A major floor 15.0% below — a decisive break under it would weaken the trend.
The nearest floor, 8.2% below — buyers have tended to step in here.
The nearest ceiling, 6.1% above — a clean break opens room to run.
A major ceiling 38.9% above — clearing it would confirm fresh momentum.
Key ADPT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ADPT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $13.94 | Sell | $13.82 | Buy |
| MA 10 | $13.45 | Buy | $13.71 | Buy |
| MA 20 | $13.74 | Buy | $13.74 | Buy |
| MA 50 | $13.85 | Sell | $14.09 | Sell |
| MA 100 | $15.16 | Sell | $14.54 | Sell |
| MA 200 | $15.14 | Sell | $14.10 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.42 | Neutral |
| Stoch RSI (14) | 74.60 | Neutral |
| CCI (20) | 15.39 | Neutral |
| Williams %R (14) | -42.93 | Info |
| MACD (12,26,9) | 0.07 | Buy |
| ROC (12) | 0.22 | Buy |
| Bollinger %B (20,2) | 0.55 | Neutral |
| Stochastic %K (14) | 57.07 | Neutral |
| TRIX (15) | -0.16 | Sell |
| Awesome (5,34) | 0.06 | Buy |
| Ultimate (7,14,28) | 62.26 | Neutral |
| Momentum (10) | 0.21 | Buy |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 14.23 | Sell |
| ADX (14) | 8.51 | Neutral |
| ATR (14) | 0.35 | Info |
The 30-day technical picture for ADPT is bullish. RSI14 is 50 and the sentiment is BULLISH.
SMA50 is $13.82 and SMA200 is $15.13, providing a near-term framework with support at $12.71 and resistance at $14.69. The 30-day range spans from $11.35 to $16.98.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $12.41 | $13.84 | $19.71 | 0% | Neutral | |
| $14.81 | $18.81 | $25.36 | +36% | Bullish | |
| $15.30 | $20.01 | $28.03 | +45% | Bullish | |
| $14.75 | $19.76 | $28.52 | +43% | Bullish | |
| $17.02 | $23.31 | $34.50 | +68% | Bullish | |
| $18.04 | $25.21 | $38.14 | +82% | Bullish | |
| $20.41 | $29.07 | $44.86 | +110% | Bullish | |
| $24.96 | $36.17 | $56.83 | +161% | Bullish | |
| $25.41 | $37.44 | $59.82 | +171% | Bullish | |
| $26.02 | $38.97 | $63.21 | +182% | Bullish | |
| $37.97 | $61.19 | $105.87 | +342% | Bullish | |
| $56.11 | $102.72 | $195.19 | +642% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $12.41 | $13.84 | $16.30 | +0.00% |
| June 2026 | $12.17 | $14.31 | $17.25 | +3.41% |
| July 2026 | $12.10 | $14.36 | $17.56 | +0.37% |
| August 2026 | $11.75 | $14.05 | $17.37 | -2.20% |
| September 2026 | $11.96 | $14.38 | $17.94 | +2.39% |
| October 2026 | $12.48 | $15.09 | $18.98 | +4.88% |
| November 2026 | $12.55 | $15.25 | $19.31 | +1.05% |
| December 2026 | $12.67 | $15.46 | $19.71 | +1.40% |
Click any year to see its month-by-month ADPT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ADPT price prediction for 2026 points to an average of $13.84 (low $12.41, high $19.71) — a potential gain of 0% on today's $13.84. Price action looks broadly range-bound.
In 2027, ADPT is projected to trade between $14.81 and $25.36, averaging $18.81 — a potential gain of +36% from today's $13.84. That is up +36% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Adaptive Biotechnologies Corporation's 2028 outlook centres on $20.01, within a $15.30 to $28.03 range. That is up +6% on the projected 2027 average. That marks a +45% change versus current levels. Momentum favours further upside here.
By 2029, ADPT could reach as high as $28.52, with a base case around $19.76 and support toward $14.75 — roughly +43% from $13.84. Buyers look set to stay in control over this stretch.
Expect ADPT to range from $17.02 to $34.50 through 2030. The $23.31 average target implies a +68% move from current prices. That is up +18% on the projected 2029 average. Momentum favours further upside here.
The ADPT price prediction for 2031 points to an average of $25.21 (low $18.04, high $38.14) — a potential gain of +82% on today's $13.84. Buyers look set to stay in control over this stretch.
In 2032, ADPT is projected to trade between $20.41 and $44.86, averaging $29.07 — a potential gain of +110% from today's $13.84. That is up +15% on the projected 2031 average. Momentum favours further upside here.
Adaptive Biotechnologies Corporation's 2033 outlook centres on $36.17, within a $24.96 to $56.83 range. That is up +24% on the projected 2032 average. That marks a +161% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, ADPT could reach as high as $59.82, with a base case around $37.44 and support toward $25.41 — roughly +171% from $13.84. Momentum favours further upside here.
Expect ADPT to range from $26.02 to $63.21 through 2035. The $38.97 average target implies a +182% move from current prices. That is up +4% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The ADPT price prediction for 2040 points to an average of $61.19 (low $37.97, high $105.87) — a potential gain of +342% on today's $13.84. Momentum favours further upside here.
In 2050, ADPT is projected to trade between $56.11 and $195.19, averaging $102.72 — a potential gain of +642% from today's $13.84. That is up +68% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ADPT today (≈ 72.254335 ADPT) could be worth
$7,422.17
+$6,422.17 (+642%) by 2050 · US Dollar
Based on the average projected ADPT price of $102.72 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ADPTwould be worth at today's price.
$1,000 invested in ADPT on May 27, 2025 (≈ 109.409186 ADPT) would be worth
$1,514.22
+$514.22 (+51.4%) today · 1.51× · US Dollar
Based on a ADPT entry price of $9.14 vs. today's $13.84.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.96 | $991.4 | -0.9% |
| 1 month ago | $14.21 | $973.96 | -2.6% |
| 3 months ago | $16.46 | $840.83 | -15.9% |
| 6 months ago | $19.66 | $703.97 | -29.6% |
| 1 year ago | $9.14 | $1,514.22 | +51.4% |
| All time (5.0y) ago | $36.63 | $377.83 | -62.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ADPT forecast.
Our base-case forecast reaches $28.00 around 2032.
Implied market cap at $28.00: $4.48B
The multi-year forecast spans 2026 through 2050, with the average price rising from $13.88 in 2026 to $100.00 in 2050. The 2026 min $12.41, avg $13.88, max $20.01; 2027 min $14.82, avg $18.92, max $25.68; 2028 min $15.10, avg $19.87, max $28.06; 2029 min $14.55, avg $19.65, max $28.61; 2030 min $16.78, avg $23.19, max $34.66.
The forecast continues with 2031 min $17.52, avg $24.73, max $37.81; 2032 min $19.92, avg $28.68, max $44.75; 2033 min $24.52, avg $35.95, max $57.16; 2034 min $24.66, avg $36.80, max $59.52; 2035 min $25.21, avg $38.28, max $62.89. For 2040: min $36.21, avg $59.42, max $104.31; 2050: min $53.18, avg $100.00, max $193.30.
ROI by year shows strong gains: 2027 36.3%, 2028 43.2%, 2029 41.6%, 2030 67.1%, 2031 78.1%, 2032 106.6%, 2033 159%, 2034 165.2%, 2035 175.8%, 2040 328.1%, 2050 620.5%. The outlook is labeled BULLISH for 2027 onward, with 2026 noted as NEUTRAL. These figures are estimates and not guarantees; actual results depend on a range of factors and market conditions.
Tap a question to reveal the answer.
Avg price $23.19 with an implied ROI of 67.1% in 2030.
The forecast shows a BULLISH sentiment from 2027 onward, with rising averages (e.g., 2027 avg $18.92; 2030 avg $23.19; 2050 avg $100.00) and positive ROIs in later years, though 2026 is Neutral. These are estimates, not guarantees.
Yes. The 2050 forecast shows an avg of $100.00 and a max of $193.30, with an ROI of 620.5%.
Current price is $13.88 and market cap is $2.22B.
Sentiment is BULLISH. RSI14 is 50, SMA50 is $13.82, SMA200 is $15.13. Support is at $12.71 and resistance at $14.69; the 30-day range is $11.35 to $16.98.
Adaptive Biotechnologies Corporation Community Discussion
0Share your Adaptive Biotechnologies Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.